Pharmafile Logo
Pharmafocus logo
Advanced Search

eye technology

Showing 1 posts of 1 posts found.

Novartis image

Novartis pays $200m for eye technology

May 22, 2014
Sales and Marketing Novartis, eye technology, fovista, ophthotech, wet and

Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …

News
The Gateway to Local Adoption Series

Latest content

START and Rome cancer institute partner to expand early-phase trial access in Italy

November 10, 2026

AbbVie expands Oxford R&D facility with new £120m UK research commitment

November 9, 2026

MedPharm appoints Jason Mieding as chief operating officer

November 8, 2026

UKRI backs five hubs developing AI tools for earlier disease detection

November 8, 2026

Coriolis Pharma appoints Teun van der Heide as CEO

November 7, 2026